Chaparral: Overview, Uses, Side Effects, Precautions, Interactions, Dosing and Reviews

Overview

Chaparral is a plant. The chaparral leaf is used to make medicine, but there are serious safety concerns with its use. The U.S. Food and Drug Administration and Health Canada have advised consumers against using products containing chaparral due to these safety concerns.

Despite serious safety concerns, people use chaparral for digestion problems, respiratory tract conditions, skin disorders, arthritis, and many other conditions, but there is no good scientific evidence to support these uses.

Uses & Effectiveness

Insufficient Evidence for

Arthritis.
Cancer.
Sexually transmitted diseases.
Tuberculosis.
Colds.
Skin conditions.
Stomach problems (cramps, gas).
Weight loss.
Urinary and respiratory infections.
Chickenpox.
Wounds.
Skin infections.
Hair growth.
Skin cancer.
Other conditions.

More evidence is needed to rate the effectiveness of chaparral for these uses.

Side Effects

When taken by mouth: Chaparral is LIKELY UNSAFE. There are several reports of serious poisoning, acute hepatitis, and kidney and liver damage, including kidney and liver failure, in people who have taken chaparral. Chaparral can also cause side effects including stomach pain, nausea, diarrhea, weight loss, and fever.

When applied to the skin: There isn't enough reliable information to know if chaparral is safe. It might cause side effects such as rash and itching in some people.

Special Precautions and Warnings

Pregnancy and breast-feeding: Chaparral is LIKELY UNSAFE. It can cause serious liver and kidney problems. Don't use products containing chaparral when pregnant or breast-feeding.

Liver disease: Chaparral might make liver disease worse. Don't use it.

Interactions

Moderate Interaction

Be cautious with this combination

Medications that can harm the liver (Hepatotoxic drugs) interacts with Chaparral
Chaparral might harm the liver. Taking chaparral along with medication that might also harm the liver can increase the risk of liver damage. Do not take chaparral if you are taking a medication that can harm the liver.

Some medications that can harm the liver include acetaminophen (Tylenol and others), amiodarone (Cordarone), carbamazepine (Tegretol), isoniazid (INH), methotrexate (Rheumatrex), methyldopa (Aldomet), fluconazole (Diflucan), itraconazole (Sporanox), erythromycin (Erythrocin, Ilosone, others), phenytoin (Dilantin), lovastatin (Mevacor), pravastatin (Pravachol), simvastatin (Zocor), and many others.

Dosing

The appropriate dose of chaparral depends on several factors such as the user's age, health, and several other conditions. At this time there is not enough scientific information to determine an appropriate range of doses for chaparral. Keep in mind that natural products are not always necessarily safe and dosages can be important. Be sure to follow relevant directions on product labels and consult your pharmacist or physician or other healthcare professional before using.

View References

REFERENCES:

Smith BC, Desmond PV. Acute hepatitis induced by ingestion of the herbal medication chaparral. Aust N Z J Med 1993;23:526..

Gordon DW, Rosenthal G, Hart J, et al. Chaparral ingestion: the broadening spectrum of liver injury caused by herbal medications. JAMA 1995;273:489-90.

Batchelor WB, Heathcote J, Wanless IR. Chaparral-induced hepatic injury. Am J Gastroenterol 1995;90:831-3.

Katz M, Saibil F. Herbal hepatitis: subacute hepatic necrosis secondary to chaparral leaf. J Clin Gastroenterol 1990;12:203-6.

Klepser TB, Klepser ME. Unsafe and potentially safe herbal therapies. Am J Health Syst Pharm 1999;56:125-38.

Sheikh NM, Philen RM, Love LA. Chaparral-associated hepatotoxicity. Arch Intern Med 1997;157:913-9.

Heron S, Yarnell E. The safety of low-dose Larrea tridentata (DC) Coville (creosote bush or chaparral): a retrospective clinical study. J Altern Complement Med 2001;7:175-85..

Chaparral-induced toxic hepatitis-California and Texas, 1992. MMWR Morb Mortal Wkly Rep 1992;41:812-4..

Estes JD, Stolpman D, Olyaei A, et al. High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure. Arch Surg 2003;138:852-8..

Anesini C, Ferraro G, Lopez P, Borda E. Different intracellular signals coupled to the antiproliferative action of aqueous crude extract from Larrea divaricata Cav. and nor-dihydroguaiaretic acid on a lymphoma cell line. Phytomedicine 2001;8:1-7..

McDonald RW, Bunjobpon W, Liu T, et al. Synthesis and anticancer activity of nordihydroguaiaretic acid (NDGA) and analogues. Anticancer Drug Des 2001;16:261-70..

Lambert JD, Zhao D, Meyers RO, et al. Nordihydroguaiaretic acid: hepatotoxicity and detoxification in the mouse. Toxicon 2002;40:1701-8..

Quiroga EN, Sampietro AR, Vattuone MA. Screening antifungal activities of selected medicinal plants. J Ethnopharmacol 2001;74:89-96..

Gnabre JN, Brady JN, Clanton DJ, et al. Inhibition of human immunodeficiency virus type 1 transcription and replication by DNA sequence-selective plant lignans. Proc Natl Acad Sci U S A 1995;92:11239-43..

Shasky DR. Contact dermatitis from Larrea tridentata (creosote bush). J Am Acad Dermatol 1986;15:302..

Smith AY, Feddersen RM, Gardner KD Jr, Davis CJ Jr. Cystic renal cell carcinoma and acquired renal cystic disease associated with consumption of chaparral tea: a case report. J Urol 1994;152:2089-91..

Huang, J. K., Chen, W. C., Huang, C. J., Hsu, S. S., Chen, J. S., Cheng, H. H., Chang, H. T., Jiann, B. P., and Jan, C. R. Nordihydroguaiaretic acid-induced Ca2+ handling and cytotoxicity in human prostate cancer cells. Life Sci 9-24-2004;75(19):2341-2351.

Abou-Gazar, H., Bedir, E., Takamatsu, S., Ferreira, D., and Khan, I. A. Antioxidant lignans from Larrea tridentata. Phytochemistry 2004;65(17):2499-2505.

Kauma, H., Koskela, R., Makisalo, H., Autio-Harmainen, H., Lehtola, J., and Hockerstedt, K. Toxic acute hepatitis and hepatic fibrosis after consumption of chaparral tablets. Scand.J Gastroenterol. 2004;39(11):1168-1171.

Uchide, N., Ohyama, K., Bessho, T., and Toyoda, H. Inhibition of influenza-virus-induced apoptosis in chorion cells of human fetal membranes by nordihydroguaiaretic Acid. Intervirology 2005;48(5):336-340.

Birkenfeld, S., Zaltsman, Y. A., Krispin, M., Zakut, H., Zor, U., and Kohen, F. Antitumor effects of inhibitors of arachidonic acid cascade on experimentally induced intestinal tumors. Dis.Colon Rectum 1987;30(1):43-46.

Leonforte, J. F. Contact dermatitis from Larrea (creosote bush). J Am Acad.Dermatol. 1986;14(2 Pt 1):202-207.

Smart, C. R., Hogle, H. H., Vogel, H., Broom, A. D., and Bartholomew, D. Clinical experience with nordihydroguaiaretic acid--"chaparrel tea" in the treatment of cancer. Rocky.Mt.Med J 1970;67(11):39-43.

Smart, C. R., Hogle, H. H., Robins, R. K., Broom, A. D., and Bartholomew, D. An interesting observation on nordihydroguaiaretic acid (NSC-4291; NDGA) and a patient with malignant melanoma--a preliminary report. Cancer Chemother.Rep. 1969;53(2):147-151.

Alderman, S., Kailas, S., Goldfarb, S., Singaram, C., and Malone, D. G. Cholestatic hepatitis after ingestion of chaparral leaf: confirmation by endoscopic retrograde cholangiopancreatography and liver biopsy. J Clin.Gastroenterol. 1994;19(3):242-247.

Obermeyer, W. R., Musser, S. M., Betz, J. M., Casey, R. E., Pohland, A. E., and Page, S. W. Chemical studies of phytoestrogens and related compounds in dietary supplements: flax and chaparral. Proc Soc Exp Biol Med 1995;208(1):6-12.

Clark, F. Chaparral-induced toxic hepatitis: California and Texas, 1992. MMWR Morb Mortal Wkly Rep. 1992;41:812-814.

Downum, KR, Dole, J, and Rodriguez, E. Nordihydroguaiaretic acid: inter- and intrapopulational variation in the Sonoran Desert creosote bush (Larrea tridentata, Zygophyllaceae). Biochem Syst Ecol 1988;16(6):551-555.

Government of Canada. Archive - Health Canada warns consumers not to take products containing chaparral. https://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2005/13575a-eng.php. Accessed September 27, 2019.

U.S. Food & Drug Administration. FDA Poisonous plant database. https://www.cfsanappsexternal.fda.gov/scripts/Plantox/Detail.CFM?ID=28. Accessed September 27, 2019.

Peralta I, Marrassini C, Saint Martin M, et al. Anti-hyperglycaemic effect and nutritional properties of an aqueous extract of Larrea divaricata Cav. (jarilla) in streptozotocin-induced diabetes in mice. J Ethnopharmacol. 2022 Oct 5;296:115429.

CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.

This copyrighted material is licensed from Therapeutic Research Center, LLC. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
Licensed from Therapeutic Research Center, LLC
Copyright © 1995-2025 by Therapeutic Research Center, LLC. All Rights Reserved.